The Canadian firm’s SpineStat assay is used to detect autoantibodies to the protein biomarker 14-3-3eta to aid the diagnosis of axial spondyloarthritis.

NEW YORK – Roche announced on Wednesday that it has received CE marking for its Chest Pain Triage algorithm to help rule in and rule out heart attacks in the emergency department.

The firm also reported its Life Sciences segment revenues fell 4 percent in the quarter, while Diagnostics revenues decreased 3 percent.

The company said during a conference call following release of its Q1 2025 results that it purchases roughly 80 percent of its supplies from sources within the US.

The Swiss healthcare firm said that the money will be used to expand its R&D, manufacturing, and distribution operations in the US.

The Australian precision diagnostics firm said it will use the money to support the launch of its proteomic tests in Australia and the US.

The company has completed its FDA submission for the system and inked a deal with UAE-based healthcare provider Burjeel Holdings to deploy the system in its facilities.

Last week, readers were most interested in a story about how the FDA could exert authority over LDTs in the future.

The company's investment in diagnostics firm Recipe is part of an effort to develop its DART mass spec tech for therapeutic drug monitoring and drugs of abuse testing.